191 related articles for article (PubMed ID: 19899955)
1. Tat-BMPs-PAMAM conjugates enhance therapeutic effect of small interference RNA on U251 glioma cells in vitro and in vivo.
Han L; Zhang A; Wang H; Pu P; Jiang X; Kang C; Chang J
Hum Gene Ther; 2010 Apr; 21(4):417-26. PubMed ID: 19899955
[TBL] [Abstract][Full Text] [Related]
2. Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo.
Kang CS; Zhang ZY; Jia ZF; Wang GX; Qiu MZ; Zhou HX; Yu SZ; Chang J; Jiang H; Pu PY
Cancer Gene Ther; 2006 May; 13(5):530-8. PubMed ID: 16410821
[TBL] [Abstract][Full Text] [Related]
3. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of folate-PAMAM for the delivery of antisense oligonucleotides to rat C6 glioma cells in vitro and in vivo.
Kang C; Yuan X; Li F; Pu P; Yu S; Shen C; Zhang Z; Zhang Y
J Biomed Mater Res A; 2010 May; 93(2):585-94. PubMed ID: 19591231
[TBL] [Abstract][Full Text] [Related]
5. [Inhibitory effect of folic acid/polyamide-amine as a miR-7 vector on the growth of glioma in mice].
Liu XZ; Su ZG; Jiang ZM; Li G; Song J; Huang K; Wang L; Chen L; Liu ZL
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):325-30. PubMed ID: 22883450
[TBL] [Abstract][Full Text] [Related]
6. Arginine modified PAMAM dendrimer for interferon beta gene delivery to malignant glioma.
Bai CZ; Choi S; Nam K; An S; Park JS
Int J Pharm; 2013 Mar; 445(1-2):79-87. PubMed ID: 23384727
[TBL] [Abstract][Full Text] [Related]
7. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
8. [Inhibitory effects of siRNA targeting epidermal growth factor receptor on proliferation and invasion of human glioblastoma cells].
Kang CS; Pu PY; Wang GX; Li YH; Dong L; Wang H
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1503-8. PubMed ID: 15500708
[TBL] [Abstract][Full Text] [Related]
9. Enhanced transfection efficiency and targeted delivery of self-assembling h-R3-dendriplexes in EGFR-overexpressing tumor cells.
Li J; Li S; Xia S; Feng J; Zhang X; Hao Y; Chen L; Zhang X
Oncotarget; 2015 Sep; 6(28):26177-91. PubMed ID: 26309162
[TBL] [Abstract][Full Text] [Related]
10. Induction of a robust immune response against avian influenza virus following transdermal inoculation with H5-DNA vaccine formulated in modified dendrimer-based delivery system in mouse model.
Bahadoran A; Ebrahimi M; Yeap SK; Safi N; Moeini H; Hair-Bejo M; Hussein MZ; Omar AR
Int J Nanomedicine; 2017; 12():8573-8585. PubMed ID: 29270010
[TBL] [Abstract][Full Text] [Related]
11. Improved tumor targetability of Tat-conjugated PAMAM dendrimers as a novel nanosized anti-tumor drug carrier.
Yan C; Gu J; Hou D; Jing H; Wang J; Guo Y; Katsumi H; Sakane T; Yamamoto A
Drug Dev Ind Pharm; 2015 Apr; 41(4):617-22. PubMed ID: 24564798
[TBL] [Abstract][Full Text] [Related]
12. Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimer.
Gao S; Li J; Jiang C; Hong B; Hao B
Drug Des Devel Ther; 2016; 10():1-11. PubMed ID: 26719669
[TBL] [Abstract][Full Text] [Related]
13. PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma.
Jiang Y; Lv L; Shi H; Hua Y; Lv W; Wang X; Xin H; Xu Q
Colloids Surf B Biointerfaces; 2016 Nov; 147():242-249. PubMed ID: 27518456
[TBL] [Abstract][Full Text] [Related]
14. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma.
Huang S; Li J; Han L; Liu S; Ma H; Huang R; Jiang C
Biomaterials; 2011 Oct; 32(28):6832-8. PubMed ID: 21700333
[TBL] [Abstract][Full Text] [Related]
15. Development of Tat-Conjugated Dendrimer for Transdermal DNA Vaccine Delivery.
Bahadoran A; Moeini H; Bejo MH; Hussein MZ; Omar AR
J Pharm Pharm Sci; 2016; 19(3):325-338. PubMed ID: 27806247
[TBL] [Abstract][Full Text] [Related]
16. Visualizing the dynamics of EGFR activity and antiglioma therapies in vivo.
Arwert E; Hingtgen S; Figueiredo JL; Bergquist H; Mahmood U; Weissleder R; Shah K
Cancer Res; 2007 Aug; 67(15):7335-42. PubMed ID: 17671203
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-modified polyamidoamine dendrimer G5-entrapped gold nanoparticles delivering METase gene inhibits gastric tumor growth via targeting CD44+ gastric cancer cells.
Li YF; Zhang HT; Xin L
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1463-1473. PubMed ID: 29858680
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of a bi-functional dendrimer-based nanovehicle co-modified with RGDyC and TAT peptides for neovascular targeting and penetration.
Li J; Zhang X; Wang M; Li X; Mu H; Wang A; Liu W; Li Y; Wu Z; Sun K
Int J Pharm; 2016 Mar; 501(1-2):112-23. PubMed ID: 26828670
[TBL] [Abstract][Full Text] [Related]
19. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional polyamidoamine-modified selenium nanoparticles dual-delivering siRNA and cisplatin to A549/DDP cells for reversal multidrug resistance.
Zheng W; Cao C; Liu Y; Yu Q; Zheng C; Sun D; Ren X; Liu J
Acta Biomater; 2015 Jan; 11():368-80. PubMed ID: 25204523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
